94 related articles for article (PubMed ID: 6403102)
1. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.
Lord JM; White SI; Bailey CJ; Atkins TW; Fletcher RF; Taylor KG
Br Med J (Clin Res Ed); 1983 Mar; 286(6368):830-1. PubMed ID: 6403102
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
[TBL] [Abstract][Full Text] [Related]
3. Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients.
Trischitta V; Gullo D; Pezzino V; Vigneri R
J Clin Endocrinol Metab; 1983 Oct; 57(4):713-8. PubMed ID: 6350337
[TBL] [Abstract][Full Text] [Related]
4. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance.
Santos RF; Nomizo R; Bopsco A; Wajchenberg BL; Reaven GM; Azhar S
Diabetes Metab; 1997 Apr; 23(2):143-8. PubMed ID: 9137903
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
[TBL] [Abstract][Full Text] [Related]
6. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes.
Santos RF; Nomizo R; Wajhenberg BL; Reaven GM; Azhar S
Diabete Metab; 1995 Oct; 21(4):274-80. PubMed ID: 8529763
[TBL] [Abstract][Full Text] [Related]
7. Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice.
Lord JM; Atkins TW; Bailey CJ
Diabetologia; 1983 Aug; 25(2):108-13. PubMed ID: 6354812
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
9. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.
Prager R; Schernthaner G; Graf H
Diabete Metab; 1986 Dec; 12(6):346-50. PubMed ID: 3817257
[TBL] [Abstract][Full Text] [Related]
10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo.
Fantus IG; Brosseau R
J Clin Endocrinol Metab; 1986 Oct; 63(4):898-905. PubMed ID: 3745404
[TBL] [Abstract][Full Text] [Related]
12. Postreceptor effect of metformin on insulin action in mice.
Lord JM; Puah JA; Atkins TW; Bailey CJ
J Pharm Pharmacol; 1985 Nov; 37(11):821-3. PubMed ID: 2867167
[TBL] [Abstract][Full Text] [Related]
13. [Action of metformin at and beyond insulin receptors. Studies in humans].
Joffroy-Lavieuville M; Noël M
Journ Annu Diabetol Hotel Dieu; 1983; ():281-6. PubMed ID: 6358619
[No Abstract] [Full Text] [Related]
14. Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes.
Pagano G; Tagliaferro V; Carta Q; Caselle MT; Bozzo C; Vitelli F; Trovati M; Cocuzza E
Diabetologia; 1983 May; 24(5):351-4. PubMed ID: 6347782
[TBL] [Abstract][Full Text] [Related]
15. Improvement of insulin action is an important part of the antidiabetic effect of metformin.
Schernthaner G
Horm Metab Res Suppl; 1985; 15():116-20. PubMed ID: 3908277
[TBL] [Abstract][Full Text] [Related]
16. Metformin and insulin receptors.
Vigneri R; Gullo D; Pezzino V
Diabetes Care; 1984; 7 Suppl 1():113-7. PubMed ID: 6376023
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of metformin in type 2 diabetes patients treated with insulin.
Wulffelé MG; Kooy A; Lehert P; Bets D; Oom JA; Borger van der Burg B; Donker AJ; Stehouwer CD
Neth J Med; 2002 Jul; 60(6):249-52. PubMed ID: 12365468
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
[TBL] [Abstract][Full Text] [Related]
19. Receptor depletion in diabetes mellitus: correction with therapy.
Eaton RP; Galagan R; Kaufman E; Allen RC; Russell L; Miller F
Diabetes Care; 1981; 4(2):299-304. PubMed ID: 7011748
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
